The Appearance of Antiphage Antibodies in Sera of Patients Treated with Phages

<b>Background</b>: Bacteriophages are neutralized by the sera of patients undergoing phage therapy (PT), particularly during local or concomitant local and oral phage administration in bone infections, soft tissue infections, or upper respiratory tract infections. <b>Methods:</b...

Full description

Saved in:
Bibliographic Details
Main Authors: Marzanna Łusiak-Szelachowska, Beata Weber-Dąbrowska, Maciej Żaczek, Ryszard Międzybrodzki, Andrzej Górski
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/14/1/87
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589329403215872
author Marzanna Łusiak-Szelachowska
Beata Weber-Dąbrowska
Maciej Żaczek
Ryszard Międzybrodzki
Andrzej Górski
author_facet Marzanna Łusiak-Szelachowska
Beata Weber-Dąbrowska
Maciej Żaczek
Ryszard Międzybrodzki
Andrzej Górski
author_sort Marzanna Łusiak-Szelachowska
collection DOAJ
description <b>Background</b>: Bacteriophages are neutralized by the sera of patients undergoing phage therapy (PT), particularly during local or concomitant local and oral phage administration in bone infections, soft tissue infections, or upper respiratory tract infections. <b>Methods:</b> The antiphage activity of the sera (AAS) level of 27 patients with bacterial infections such as bone infections, soft tissue infections, or upper respiratory tract infections undergoing PT was performed using the plate phage neutralization test. <b>Results:</b> Our preliminary results suggest that high levels of antiphage antibodies appear late in the treatment period, at the earliest in the 3rd–8th week of PT. Patients with bone infections treated locally with the <i>S. aureus</i> phage Staph_1N and patients with upper respiratory tract infections administered locally and orally with the <i>S. aureus</i> phage Staph_A5L had elevated levels of antiphage antibodies in sera during PT. In parallel to these results, it has been shown that a strong antiphage humoral response does not prevent a positive outcome of phage treatment. <b>Conclusions:</b> The earliest time point at which high levels of antiphage antibodies in sera appear during local and oral PT is day 21 of therapy. We noticed that the high level of antiphage antibodies in sera occurring during local or both local and oral PT was correlated with the type of infection and phage type.
format Article
id doaj-art-654af417db694957adb853e61f740075
institution Kabale University
issn 2079-6382
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj-art-654af417db694957adb853e61f7400752025-01-24T13:18:55ZengMDPI AGAntibiotics2079-63822025-01-011418710.3390/antibiotics14010087The Appearance of Antiphage Antibodies in Sera of Patients Treated with PhagesMarzanna Łusiak-Szelachowska0Beata Weber-Dąbrowska1Maciej Żaczek2Ryszard Międzybrodzki3Andrzej Górski4Bacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (HIIET PAS), 53-114 Wrocław, PolandBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (HIIET PAS), 53-114 Wrocław, PolandBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (HIIET PAS), 53-114 Wrocław, PolandBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (HIIET PAS), 53-114 Wrocław, PolandBacteriophage Laboratory, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences (HIIET PAS), 53-114 Wrocław, Poland<b>Background</b>: Bacteriophages are neutralized by the sera of patients undergoing phage therapy (PT), particularly during local or concomitant local and oral phage administration in bone infections, soft tissue infections, or upper respiratory tract infections. <b>Methods:</b> The antiphage activity of the sera (AAS) level of 27 patients with bacterial infections such as bone infections, soft tissue infections, or upper respiratory tract infections undergoing PT was performed using the plate phage neutralization test. <b>Results:</b> Our preliminary results suggest that high levels of antiphage antibodies appear late in the treatment period, at the earliest in the 3rd–8th week of PT. Patients with bone infections treated locally with the <i>S. aureus</i> phage Staph_1N and patients with upper respiratory tract infections administered locally and orally with the <i>S. aureus</i> phage Staph_A5L had elevated levels of antiphage antibodies in sera during PT. In parallel to these results, it has been shown that a strong antiphage humoral response does not prevent a positive outcome of phage treatment. <b>Conclusions:</b> The earliest time point at which high levels of antiphage antibodies in sera appear during local and oral PT is day 21 of therapy. We noticed that the high level of antiphage antibodies in sera occurring during local or both local and oral PT was correlated with the type of infection and phage type.https://www.mdpi.com/2079-6382/14/1/87antiphage antibodyduration of phage therapyphage neutralization of seraphage therapy
spellingShingle Marzanna Łusiak-Szelachowska
Beata Weber-Dąbrowska
Maciej Żaczek
Ryszard Międzybrodzki
Andrzej Górski
The Appearance of Antiphage Antibodies in Sera of Patients Treated with Phages
Antibiotics
antiphage antibody
duration of phage therapy
phage neutralization of sera
phage therapy
title The Appearance of Antiphage Antibodies in Sera of Patients Treated with Phages
title_full The Appearance of Antiphage Antibodies in Sera of Patients Treated with Phages
title_fullStr The Appearance of Antiphage Antibodies in Sera of Patients Treated with Phages
title_full_unstemmed The Appearance of Antiphage Antibodies in Sera of Patients Treated with Phages
title_short The Appearance of Antiphage Antibodies in Sera of Patients Treated with Phages
title_sort appearance of antiphage antibodies in sera of patients treated with phages
topic antiphage antibody
duration of phage therapy
phage neutralization of sera
phage therapy
url https://www.mdpi.com/2079-6382/14/1/87
work_keys_str_mv AT marzannałusiakszelachowska theappearanceofantiphageantibodiesinseraofpatientstreatedwithphages
AT beataweberdabrowska theappearanceofantiphageantibodiesinseraofpatientstreatedwithphages
AT maciejzaczek theappearanceofantiphageantibodiesinseraofpatientstreatedwithphages
AT ryszardmiedzybrodzki theappearanceofantiphageantibodiesinseraofpatientstreatedwithphages
AT andrzejgorski theappearanceofantiphageantibodiesinseraofpatientstreatedwithphages
AT marzannałusiakszelachowska appearanceofantiphageantibodiesinseraofpatientstreatedwithphages
AT beataweberdabrowska appearanceofantiphageantibodiesinseraofpatientstreatedwithphages
AT maciejzaczek appearanceofantiphageantibodiesinseraofpatientstreatedwithphages
AT ryszardmiedzybrodzki appearanceofantiphageantibodiesinseraofpatientstreatedwithphages
AT andrzejgorski appearanceofantiphageantibodiesinseraofpatientstreatedwithphages